China Health Resource Announces Go Global Initiative For New Product Introductions
SICHUAN, China, July 19, 2012 /PRNewswire-Asia/ — China Health Resource, Inc. (OTCBB: CHRI), today announced is expanding the company’s Go Global Initiative to include the Migraine market and has appointed a task force to be headed by Ms. Cynthia Bitting to undertake USA strategic alliances under the Go Global Initiative.
“Response to our newly developed Toufeng Migraine tablet has been overwhelming; we decided our Go Global Initiative platform must immediately be expanded to include strategic alliances for this new revolutionary Toufeng Migraine tablet and other’s. Discussions with Herborium Group Inc. have been discontinued by CHRI,” said Mr. Jiayin Wang, Chairman and CEO of CHRI.
“The Company while protecting its Chinese operation franchise, is looking forward to significant expansion through new product introduction and commercialization in the USA and globally,” says Cynthia Bitting, Head of Strategic Alliances/Go Global Initiative.
“The Company has experienced strong growth each quarter and while protecting its high growth franchise is looking forward to continued expansion through new product introduction and development. Our franchise in our Chinese operations continues to be strong and demand for our products continues despite a general slowing in the Chinese economy. Now, our investment in research and development is beginning to reap rewards with the addition of our new migraine solution, Toufeng Migraine tablet. CHRI is looking for strong strategic alliances to expand into new markets. I am very pleased with the appointment of Ms. Cynthia Bitting to head our Go Global Initiative Strategic Alliances,” said Jiayin Wang, CEO of CHRI.
China Health Resource, Inc. engages in the development, manufacturing, processing, marketing and sale of raw and pharmaceutical TCM products including Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae (and other products derived from the highest quality Chinese herbs). It is the only the provider of GAP quality DAR in the People’s Republic of China under the registered Trademark Chuan Baizhi(TM). DAR, which is also known as “Bai Zhi” in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The Company’s DAR-related products include the Bailing Capsule and Yisheng Capsule. The Company was founded in 2001 and has operations in Suining, Sichuan Province.
For more information visit www.chinahealthresource.com
Certain statements in this document regarding financial matters, other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute “forward-looking statements” within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words “believe”, “expect”, “anticipate”, “optimistic”, “intend”, “will”, and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company’s actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.
Ms. Cynthia Bitting
Contact Tel. +1 314-442-0368(USA)
SOURCE China Health Resource, Inc.